3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
6
Plasma cell
4
Lymphoid
4
Classical hematology
4
Myeloid
3
Thoracic
2
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
586
Uterine Cervical Neoplasms
497
Endometrial Neoplasms
319
Breast Neoplasms
140
Uterine Cervical Dysplasia
103
Neoplasms
102
Carcinoma, Ovarian Epithelial
90
Fallopian Tube Neoplasms
78
Lung Neoplasms
65
Colorectal Neoplasms
64
Uterine Neoplasms
61
Vulvar Neoplasms
56
Pancreatic Neoplasms
56
Papillomavirus Infections
53
Prostatic Neoplasms
52
Stomach Neoplasms
49
Colonic Neoplasms
47
Peritoneal Neoplasms
41
Melanoma
39
Urinary Bladder Neoplasms
37
Carcinoma, Non-Small-Cell Lung
37
Esophageal Neoplasms
36
Head and Neck Neoplasms
32
Pelvic Neoplasms
29
Vaginal Neoplasms
28
Recurrence
28
Rectal Neoplasms
27
Ovarian Cysts
27
Endometrial Hyperplasia
26
Sarcoma
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hemostatic Disorders
×
Gynecologic
×
Clear all
NCT07397715
2026-02-12
MUSA3
Swiss GO Trial Group
Recruiting
1,000 enrolled